» Articles » PMID: 37232773

Pre-Chemotherapy Dental Screening: Is There Additional Diagnostic Value for a Panoramic Radiograph?

Overview
Journal Dent J (Basel)
Specialty Dentistry
Date 2023 May 26
PMID 37232773
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The oral cavity is a potential source of infectious complications in patients treated with myelosuppressive chemotherapy (CT). Pre-chemotherapy oral examination to identify foci of infection is recommended, but it is unclear whether this should include panoramic radiography. The present study aimed to evaluate the additional diagnostic merit of panoramic radiography as part of pre-CT oral screening.

Methods: Patients with solid tumors scheduled to receive a myelosuppressive CT were eligible. The foci definition followed the guidelines of the Dutch Association of Maxillofacial Surgery. Oral foci assessed by clinical evaluation and panoramic radiography were compared.

Results: In 33 out of 93 patients (35.5%), one or more foci were identified by clinical examination, whereas in 49.5% of patients, panoramic radiography showed pathology. In 19 patients, an oral focus was missed by clinical examination only, whereas in 11 patients, panoramic radiography indicated periodontal bone loss, but advanced periodontitis was not substantiated by clinical examination.

Conclusions: Panoramic radiographs complement clinical examinations and have additional diagnostic value. Nevertheless, the additional merit seems small, and the clinical relevance may vary depending on the anticipated risk of developing oral complications and the need for detailed diagnosis and rigorous elimination of oral foci prior to the start of cancer therapy.

Citing Articles

Oral microbial changes, oral mucositis and febrile neutropenia during myelosuppressive chemotherapy in patients diagnosed with a solid tumor or lymphoma.

Zecha J, Raber-Durlacher J, Brandt B, Buijs M, Zaura E, de Lange J Front Oral Health. 2024; 5:1461463.

PMID: 39610787 PMC: 11602456. DOI: 10.3389/froh.2024.1461463.

References
1.
Yong C, Robinson A, Hong C . Dental Evaluation Prior to Cancer Therapy. Front Oral Health. 2022; 3:876941. PMC: 9058061. DOI: 10.3389/froh.2022.876941. View

2.
. Oral complications of cancer therapies: diagnosis, prevention, and treatment. Natl Inst Health Consens Dev Conf Consens Statement. 1989; 7(7):1-11. View

3.
Barbieri Ortigara G, Bonzanini L, Schulz R, Linhares Ferrazzo K . Late radiation effects in survivors of head and neck cancer: State of the science. Crit Rev Oncol Hematol. 2021; 162:103335. DOI: 10.1016/j.critrevonc.2021.103335. View

4.
Schuurhuis J, Stokman M, Witjes M, Dijkstra P, Vissink A, Spijkervet F . Evidence supporting pre-radiation elimination of oral foci of infection in head and neck cancer patients to prevent oral sequelae. A systematic review. Oral Oncol. 2014; 51(3):212-20. DOI: 10.1016/j.oraloncology.2014.11.017. View

5.
Elad S, Thierer T, Bitan M, Shapira M, Meyerowitz C . A decision analysis: the dental management of patients prior to hematology cytotoxic therapy or hematopoietic stem cell transplantation. Oral Oncol. 2007; 44(1):37-42. DOI: 10.1016/j.oraloncology.2006.12.006. View